Life ScienceCompany
Sumitovant Biopharma M&A Summary
Sumitovant Biopharma has acquired 1 company, including 1 in the last 5 years.
Sumitovant Biopharma’s largest acquisition to date was in 2020, when it acquired Urovant Sciences for $584M. Sumitovant Biopharma has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Sumitovant Biopharma Business Overview
Where is Sumitovant Biopharma headquartered?
Sumitovant Biopharma is headquartered in New York, New York.
What sector is Sumitovant Biopharma in?
Sumitovant Biopharma is a life science company.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Advisors 2